The Pharmacogenomics Journal - Table of Contents alert Volume 13 Issue 5

TABLE OF CONTENTS Volume 13, Issue 5 (October 2013) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe HIV infection may raise risk of cocaine abuse - The latest Neuropsychopharmacology podcast is now available! In this podcast, Dr. Jay P. McLaughlin discusses how a protein associated with HIV infection, called HIV-1 Tat, may increase vulnerability for drug addiction.  Listen to the podcast for FREE  Dr Jay P. McLaughlin's accompanying original article is available to read here.   Review Top Evaluation of predictive tests for screening for dihydropyrimidine dehydrogenase deficiency M C van Staveren, H Jan Guchelaar, A B P van Kuilenburg, H Gelderblom and J G Maring Pharmacogenomics J 2013 13: 389-395; advance online publication, July 16, 2013; 10.1038/tpj.2013.25 Abstract | Full Text Original Articles Top Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression T D Nguyen, S Markova, W Liu, J M Gow, R M Baldwin, M Habashian, M V Relling, M J Ratain and D L Kroetz Pharmacogenomics J 2013 13: 396-402; advance online publication, June 5, 2012; 10.1038/tpj.2012.20 Abstract | Full Text A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen E Cecchin, M D'Andrea, S Lonardi, C Zanusso, N Pella, D Errante, E De Mattia, J Polesel, F Innocenti and G Toffoli Pharmacogenomics J 2013 13: 403-409; advance online publication, August 7, 2012; 10.1038/tpj.2012.31 Abstract | Full Text Intratumoral expression profiling of genes involved in angiogenesis in colorectal cancer patients treated with chemotherapy plus the VEGFR inhibitor PTK787/ZK 222584 (vatalanib) P M Wilson, D Yang, M Azuma, M M Shi, K D Danenberg, D Lebwohl, A Sherrod, R D Ladner, W Zhang, P V Danenberg, T Trarbach, G Folprecht, G Meinhardt and H-J Lenz Pharmacogenomics J 2013 13: 410-416; advance online publication, June 5, 2012; 10.1038/tpj.2012.23 Abstract | Full Text A genome-wide association study for irinotecan-related severe toxicities in patients with advanced non-small-cell lung cancer J-Y Han, E S Shin, Y-S Lee, H Y Ghang, S-Y Kim, J-A Hwang, J Y Kim and J S Lee Pharmacogenomics J 2013 13: 417-422; advance online publication, June 5, 2012; 10.1038/tpj.2012.24 Abstract | Full Text Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies? M Loh, D Chua, Y Yao, R A Soo, K Garrett, N Zeps, C Platell, T Minamoto, K Kawakami, B Iacopetta and R Soong Pharmacogenomics J 2013 13: 423-429; advance online publication, June 26, 2012; 10.1038/tpj.2012.26 Abstract | Full Text Association of KCNJ1 variation with change in fasting glucose and new onset diabetes during HCTZ treatment J H Karnes, C W McDonough, Y Gong, T T Vo, T Y Langaee, A B Chapman, J G Gums, A L Beitelshees, K R Bailey, J L Del-Aguila, E A Boerwinkle, C J Pepine, S T Turner, J A Johnson and R M Cooper-DeHoff Pharmacogenomics J 2013 13: 430-436; advance online publication, August 21, 2012; 10.1038/tpj.2012.34 Abstract | Full Text VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction R Lacchini, J J Muniz, Y T D A Nobre, A J Cologna, A C P Martins and J E Tanus-Santos Pharmacogenomics J 2013 13: 437-442; advance online publication, September 25, 2012; 10.1038/tpj.2012.39 Abstract | Full Text Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis OPEN E Croze, K D Yamaguchi, V Knappertz, A T Reder and H Salamon Pharmacogenomics J 2013 13: 443-451; advance online publication, June 19, 2012; 10.1038/tpj.2012.27 Abstract | Full Text Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6 N González-Vacarezza, F Abad-Santos, A Carcas-Sansuan, P Dorado, E Peñas-LLedó, F Estévez-Carrizo and A LLerena Pharmacogenomics J 2013 13: 452-455; advance online publication, June 26, 2012; 10.1038/tpj.2012.29 Abstract | Full Text Pharmacogenomics of selective serotonin reuptake inhibitor treatment for major depressive disorder: genome-wide associations and functional genomics Y Ji, J M Biernacka, S Hebbring, Y Chai, G D Jenkins, A Batzler, K A Snyder, M S Drews, Z Desta, D Flockhart, T Mushiroda, M Kubo, Y Nakamura, N Kamatani, D Schaid, R M Weinshilboum and D A Mrazek Pharmacogenomics J 2013 13: 456-463; advance online publication, August 21, 2012; 10.1038/tpj.2012.32 Abstract | Full Text Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder F W Lohoff, S Narasimhan and K Rickels Pharmacogenomics J 2013 13: 464-469; advance online publication, August 21, 2012; 10.1038/tpj.2012.33 Abstract | Full Text Interaction of SLC1A1 gene variants and life stress on pharmacological resistance in obsessive–compulsive disorder E Real, M Gratacòs, J Labad, P Alonso, G Escaramís, C Segalàs, M Subirà, C López-Solà, X Estivill and J M Menchón Pharmacogenomics J 2013 13: 470-475; advance online publication, July 10, 2012; 10.1038/tpj.2012.30 Abstract | Full Text Association of a carboxylesterase 1 polymorphism with appetite reduction in children and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate E M Bruxel, A Salatino-Oliveira, J P Genro, C P Zeni, G V Polanczyk, R Chazan, L A Rohde and M H Hutz Pharmacogenomics J 2013 13: 476-480; advance online publication, June 12, 2012; 10.1038/tpj.2012.25 Abstract | Full Text Advertisement Have you read these not to be missed articles published in Translational Psychiatry in 2013?  Monozygotic twins affected with major depressive disorder have greater variance in methylation than their unaffected co-twin   Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder    Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.